English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduDr. Sabik’s exemplary career spans three decades, marked by significant contributions to cardiac surgery and medical education. He earned his Bachelor of Science in Life Sciences from the Massachusetts Institute of Technology and his medical degree from Harvard Medical School. His postgraduate training includes a general surgery residency at Massachusetts General Hospital and a thoracic and cardiovascular surgery residency at the Cleveland Clinic, where he later became Chairman of the Department of Thoracic and Cardiovascular Surgery.
Throughout his career, Dr. Sabik has demonstrated a steadfast commitment to advancing the field of cardiothoracic surgery. His specialty interests include adult cardiac surgery, valvular heart disease, coronary artery disease, surgery of the thoracic aorta, minimally invasive cardiac surgery, and off-pump coronary artery bypass surgery.
As a notable researcher, he served as co-principal investigator for the landmark EXCEL trial, comparing drug-eluting stents in select patients with left main coronary artery disease. The results were published in The New England Journal of Medicine. Other numerous studies he authored or co-authored have been published in The Annals of Thoracic Surgery, The Journal of Thoracic and Cardiovascular Surgery, and Journal of American Society of Echocardiography.
In addition to serving on the STS Board of Directors, Dr. Sabik held positions on several of the Society’s councils and committees, including the Finance Committee; Council on Clinical Practice and Member Engagement; Council on Quality, Research, and Patient Safety; and Council on Health Policy and Relationships.
As STS President, Dr. Sabik aims to further the organization’s mission by enhancing the quality and accessibility of data to inform best practices and improve patient outcomes, supporting innovative studies that push the boundaries of cardiothoracic medicine, and providing surgeons with cutting-edge training to refine their skills and adopt new techniques.
“I am deeply honored to serve as the president of The Society of Thoracic Surgeons and to lead this remarkable organization in 2025,” said Dr. Sabik. “STS has been at the forefront of advancing excellence in cardiothoracic surgery, and I look forward to working alongside our dedicated members to foster innovation, enhance education, and strengthen advocacy efforts that benefit both our profession and the patients we serve.”
Dr. Sabik’s leadership is expected to guide STS in its ongoing efforts to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.
Also elected during the Annual Meeting were Vinay Badhwar, MD, as First Vice President, and Vinod Thourani, MD, as Second Vice President.
Other key positions include Lisa Tchouta, MD, elected as Resident Director; Minoru Ono, MD, elected as International Director; Sigrid Sandner, MD, elected as International Director; Jessica Donington, MD, elected as Director-at-Large; and Felix Fernandez, MD, elected as Director-at-Large.
Wilson Szeto, MD, was re-elected as Secretary; John Mitchell, MD, was elevated to Treasurer; and Anthony Estrera, MD, was re-elected as Director-at-Large.
# # #
About STS
Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing more than 7,800 cardiothoracic surgeons, researchers, and allied healthcare professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society’s mission is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.
